Machine Learning in Bioinformatics of Protein Sequences 2022
DOI: 10.1142/9789811258589_0011
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Cancer Hotspot Residues and Driver Mutations Using Machine Learning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…However, ethical considerations, including patient consent and data security, should be addressed in the implementation of AI-driven precision oncology. The study in [16] focuses on the identification of cancer hotspot residues and driver mutations using machine learning. Their work underscores the importance of machine learning in identifying critical genetic variations in cancer.…”
Section: Literature Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…However, ethical considerations, including patient consent and data security, should be addressed in the implementation of AI-driven precision oncology. The study in [16] focuses on the identification of cancer hotspot residues and driver mutations using machine learning. Their work underscores the importance of machine learning in identifying critical genetic variations in cancer.…”
Section: Literature Reviewmentioning
confidence: 99%
“…This manual approach not only consumes valuable time but also introduces the potential for inaccuracies, ultimately impeding the precision and efficiency of precision medicine practices [15]. In light of these challenges, there is an urgent need for innovative solutions that can alleviate the burden on healthcare professionals while simultaneously enhancing the accuracy of genetic variation classification within the precision medicine framework [16][17][18][19]. Here, the integration of advanced technologies, particularly machine learning, emerges as a promising avenue to address this critical issue.…”
Section: Introductionmentioning
confidence: 99%
“…Current research in cancer is focused on studying the mutations in the cancer genomes to identify specific mutations in protein domains that may be associated with a poor prognosis [ 55 ]. Bioinformatics studies of mutations in protein domains in ovarian cancer also reveal therapeutic targets and prognostic indicators [ 56 ].…”
Section: Introductionmentioning
confidence: 99%